ClinicalTrials.Veeva

Menu

Indomethacin and Cardiac Bypass Surgery

Q

Queen's University

Status and phase

Completed
Phase 4

Conditions

Hemorrhage

Treatments

Drug: Acetaminophen & Indomethacin
Drug: Acetaminophen
Drug: Indomethacin

Study type

Interventional

Funder types

Other

Identifiers

NCT01073670
ANAE-062-00

Details and patient eligibility

About

Following signed informed consent, patients scheduled for elective cardiac surgery were randomly assigned to one of 3 groups to be given acetaminophen, Indomethacin or a combination of both immediately following induction and then at 6, 12, 18 & 24 hours following surgery. Our primary outcome measure was the amount of blood drained from the mediastinal tubes and chest drains. Secondary outcome measures included conventional blood coagulation indices as well as other measures of clotting as indicated by thromboelastography (TEG). Other secondary outcome measures included consumption of morphine equivalents and pain scores.

Enrollment

82 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • scheduled to undergo either elective coronary artery bypass or single valve replacement
  • normal platelet count
  • normal prothrombin time
  • normal partial thromboplastin time
  • normal serum creatinine

Exclusion criteria

  • sensitivity to study drugs
  • history of bleeding diathesis
  • renal dysfunction
  • active peptic ulcer

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

82 participants in 3 patient groups

Acetaminophen
Active Comparator group
Description:
Participants received a loading dose of acetaminophen (2600 mg) at induction followed by 1300 mg at 6, 12, 18 and 24 hours following cardiac bypass surgery.
Treatment:
Drug: Acetaminophen
Indomethacin
Experimental group
Description:
Participants were given 100 mg of indomethacin at induction and then 50 mg at 6, 12, 18 and 24 hours following cardiac bypass surgery.
Treatment:
Drug: Indomethacin
Combination
Experimental group
Description:
Participants were given a loading dose of 1300 mg of acetaminophen and 50 mg of Indomethacin followed by 650mg of acetaminophen and 25 mg of indomethacin at 6, 12, 18 and 24 hours following cardiac bypass surgery.
Treatment:
Drug: Acetaminophen & Indomethacin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems